Hepion Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Hepion Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $13.92 million for the year ending 2019.

  • Hepion Pharmaceuticals, Inc. showed an increase of +391.6% in Cash And Cash Equivalents At Carrying Value from 2018 to 2019.
  • This data is from Hepion Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on May 14, 2020.
  • XBRL data for this metric is available from 2016 to 2019 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2016 to 2019), Hepion Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 88.0%.
  • Historical annual values: Fiscal year 2019: $13.92 million | Fiscal year 2018: $2.83 million | Fiscal year 2017: $5.95 million | Fiscal year 2017: $12.98 million | Fiscal year 2016: $7.40 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: